Morgan Stanley Downgrades Bristol-Myers Squibb Co. (BMY) to Equalweight

August 5, 2016 1:24 PM EDT
Get Alerts BMY Hot Sheet
Price: $57.04 +3.28%

Rating Summary:
    10 Buy, 12 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade BMY Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Morgan Stanley downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $75.32 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Morgan Stanley

Add Your Comment